Literature DB >> 7399679

Muramyl dipeptide-induced adjuvant arthritis.

S Nagao, A Tanaka.   

Abstract

Muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine, induced adjuvant arthritis in WKA rats when injected in a water-in-oil emulsion prepared with Freund incomplete adjuvant (Difco), but not when emulsified with Drackeol and Arlacel A.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7399679      PMCID： PMC550979          DOI： 10.1128/iai.28.2.624-626.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  25 in total

1.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLS.

Authors:  C M PEARSON; F D WOOD
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

2.  Modulation of myelopoiesis by different bacterial cell-wall components: induction of colony-stimulating activity (by pure preparations, low-molecular-weight degradation products, and a synthetic low-molecular analog of bacterial cell-wall components) in vitro.

Authors:  F G Staber; R H Gisler; G Schumann; L Tarcsay; E Schläfli; P Dukor
Journal:  Cell Immunol       Date:  1978-04       Impact factor: 4.868

3.  Immunogenicity and arthritogenicity in the rat of an antigen from Mycobacterium tuberculosis wax D.

Authors:  T Koga; C M Pearson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

4.  Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes.

Authors:  D J Whitehouse; M W Whitehouse; C M Pearson
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

5.  Freund's adjuvants: relationship of arthritogenicity and adjuvanticity in rats to vehicle composition.

Authors:  M W Whitehouse; K J Orr; F W Beck; C M Pearson
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

6.  Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease.

Authors:  F Quagliata; J M Phillips-Quagliata
Journal:  Cell Immunol       Date:  1972-01       Impact factor: 4.868

7.  Structural requirements for arthritogenicity of peptidoglycans from Staphylococcus aureus and Lactobacillus plant arum and analogous synthetic compounds.

Authors:  O Kohashi; C M Pearson; Y Watanabe; S Kotani; T Koga
Journal:  J Immunol       Date:  1976-06       Impact factor: 5.422

8.  Inhibition of macrophage migration by muramyl peptides.

Authors:  S Nagao; A Tanaka; Y Yamamoto; T Koga; K Onoue; T Shiba; K Kusumoto; S Kotani
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

9.  Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.

Authors:  A Tanaka; S Nagao; R Nagao; S Kotani; T Shiba; S Kusumoto
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

10.  Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.

Authors:  K Emori; A Tanaka
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441
View more
  21 in total

1.  Antibodies to peptidoglycan in patients with spondylarthritis: a clue to disease aetiology?

Authors:  H Park; H R Schumacher; A R Zeiger; J T Rosenbaum
Journal:  Ann Rheum Dis       Date:  1984-10       Impact factor: 19.103

2.  Two adjuvant-active muramyl dipeptide analogs induce differential production of lymphocyte-activating factor and a factor causing distress in guinea pigs.

Authors:  N E Byars
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

Review 3.  Muramyl peptides. Chemical structure, biological activity and mechanism of action.

Authors:  A Adam; J F Petit; P Lefrancier; E Lederer
Journal:  Mol Cell Biochem       Date:  1981-12-04       Impact factor: 3.396

4.  Different effect of cyclosporin A on arthritides induced by a muramyl dipeptide analogue or the complete adjuvant in rats.

Authors:  T Sugawara; S Takada; K Furuhama; S Takayama; M Nomura; M Kato
Journal:  Int J Exp Pathol       Date:  1995-06       Impact factor: 1.925

5.  Arthritogenic activity of a synthetic immunoadjuvant, muramyl dipeptide.

Authors:  Z Zídek; K Maśek; Z Jiricka
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

6.  Epithelioid granuloma induced by muramyl dipeptide in immunologically deficient rats.

Authors:  S Nagao; F Ota; K Emori; K Inoue; A Tanaka
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

7.  Analysis of in vitro polyclonal B cell differentiation responses to bacterial peptidoglycan and pokeweed mitogen in rheumatoid arthritis.

Authors:  I Pardo; C Carafa; R Dziarski; A I Levinson
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

8.  Anti-inflammatory effects of muramyl dipeptide in experimental models of acute inflammation.

Authors:  Z Zídek; K Masek; F Sedivý
Journal:  Agents Actions       Date:  1984-01

9.  Degradation of muramyl dipeptide by mammalian serum.

Authors:  J Harrison; A Fox
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions.

Authors:  M R Gold; C L Miller; R I Mishell
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.